ClinicalTrials.gg
WithdrawnNCT03646916Updated Jan 22, 2021

Intraoperative Dexamethasone and Its Effect on Hyperglycemia

A Phase 4 interventional study of Dexamethasone and No dexamethasone in Diabetes Mellitus, sponsored by Ascension Health. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-22.

Sponsored by Ascension Health · Phase 4, Interventional, and Supportive care

Why this study was withdrawn
Lack of patients

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 13 studies testing dexamethasone in Diabetes Mellitus — 1 open to participants now, 1 under way, none of them phase 3. Dexamethasone · Diabetes Mellitus.

Enrollment
11th of 13
0 · median 30
Started
2020
the only one that year
Phase 4
5 of 13
none open now
Registered
11th of 13
by date
Lead sponsor
1 of 13
Ascension Health

Among the 13 studies testing dexamethasone in Diabetes Mellitus, this one is the 11th largest by enrollment, is the only one that started in 2020, is one of 5 in phase 4, and was the 11th registered.

Diabetes Mellitus

8,293 studies on the registry are indexed under Diabetes Mellitus; 1,074 are open to participants now.

Browse Diabetes Mellitus studies →

Open to participants now

1 of the 13 studies testing dexamethasone in Diabetes Mellitus is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About dexamethasone

Dexamethasone: first FDA approval 1958 (DECADRON), first EMA approval 2010. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 650 Diabetes Mellitus studies recruiting now, 357 (55%) set no upper age limit and 197 (30%) stop at 75 or younger; 88 take children under 18; 183 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies testing dexamethasone in Diabetes Mellitus, or all of them as a file.
02

Study summary

To study the effect of intra-operative dexamethasone on the management of post-operative blood sugar in diabetic patients.

03

Conditions studied

  • Diabetes Mellitus

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • documented history of Type I or Type II Diabetes Mellitus
  • scheduled for surgery that requires patients to be admitted for at least 24 hours post-surgery

Exclusion criteria

Exclusion Criteria:

  • Patients on therapy
  • Pregnant women
  • Patients at low risk for nausea/vomiting
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Dexamethasone

    Drug: Dexamethasone · Other: No dexamethasone

  • No intervention
    Non-treatment

Interventions

  • Gluco-corticosteroid

  • OtherNo dexamethasone

    Nothing

06

What researchers measure

Primary outcomes

  1. Post-operative blood sugar

    Time frame: 24 hour Post surgery

07

Study locations

1 site
  • Genesys Regional Medical Center
    Grand Blanc, Michigan 48439, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2020 to primary completion in Dec 2020, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2018
First posted
Aug 24, 2018
StartActual
Sep 15, 2020
Primary completionActual
Dec 31, 2020
CompletionActual
Dec 31, 2020
Last update
Jan 22, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03646916
Lead sponsor
Ascension Health
Responsible party
Tarik Wasfie, MD (Principal Investigator, Ascension Health) — Principal investigator
First posted
Aug 24, 2018
Start date
Sep 15, 2020
Primary completion
Dec 31, 2020
Completion
Dec 31, 2020
Last update
Jan 22, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Dexamethasone

Start the discussion